Australia markets closed

Hemagen Diagnostics, Inc. (HMGN)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00000.0000 (0.00%)
At close: 02:25PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 441.76k
Enterprise value 441.76k
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.10
Price/book (mrq)N/A
Enterprise value/revenue 0.11
Enterprise value/EBITDA -1.61

Trading information

Stock price history

Beta (5Y monthly) 0.22
52-week change 30.00%
S&P500 52-week change 326.27%
52-week high 30.0001
52-week low 30.0000
50-day moving average 30.0001
200-day moving average 30.0001

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 515.5M
Implied shares outstanding 63.88B
Float 8N/A
% held by insiders 10.00%
% held by institutions 10.00%
Shares short (11 Mar 2003) 4N/A
Short ratio (11 Mar 2003) 40.11
Short % of float (11 Mar 2003) 4N/A
Short % of shares outstanding (11 Mar 2003) 40.00%
Shares short (prior month 10 Jan 2003) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Sept 2012
Most-recent quarter (mrq)30 Sept 2012

Profitability

Profit margin -22.45%
Operating margin (ttm)-4.99%

Management effectiveness

Return on assets (ttm)-10.27%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)4.04M
Revenue per share (ttm)0.26
Quarterly revenue growth (yoy)-23.60%
Gross profit (ttm)N/A
EBITDA -273.66k
Net income avi to common (ttm)-907.32k
Diluted EPS (ttm)-0.0000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)66.29k
Total cash per share (mrq)0
Total debt (mrq)5.03M
Total debt/equity (mrq)N/A
Current ratio (mrq)1.07
Book value per share (mrq)-0.23

Cash flow statement

Operating cash flow (ttm)-358.69k
Levered free cash flow (ttm)-115.85k